Vitae Pharmaceuticals, Inc. Adds To Leadership Team With Appointment Of Arthur Fratamico As Chief Business Officer, Richard Morris As Chief Financial Officer

FORT WASHINGTON, Pa., July 8, 2014 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on discovering and developing small molecule drugs, today announced that Art Fratamico, MBA, has been named Chief Business Officer and Richard Morris, CPA, has joined the company as Chief Financial Officer. Mr. Fratamico oversees Vitae’s corporate and business development plans. Mr. Morris has assumed responsibility for the company’s finance, investor relations and administration departments.

Help employers find you! Check out all the jobs and post your resume.